Crystal structure and functional dissection of the cytostatic cytokine oncostatin M

被引:53
作者
Deller, MC
Hudson, KR
Ikemizu, S
Bravo, J
Jones, EY
Heath, JK
机构
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Canc Res Campaign, Div Struct Biol,Receptor Struct Grp, Oxford OX3 7BN, England
[2] Univ Birmingham, Sch Biochem, Canc Res Campaign, Growth Factors, Birmingham B15 2TT, W Midlands, England
来源
STRUCTURE WITH FOLDING & DESIGN | 2000年 / 8卷 / 08期
基金
英国惠康基金;
关键词
four-helix bundle cytokine; gp130; binding; oncostatin M; structure-function;
D O I
10.1016/S0969-2126(00)00176-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The cytokine oncostatin M (OSM) inhibits growth of certain tumour-derived cells, induces proliferation in other cell types (e.g. haemangioblasts) and is a mediator of inflammatory responses. Its mechanism of action is via specific binding to gp130 and either the leukaemia inhibitory factor receptor (LIFR) or oncostatin M receptor (OSMR) systems at the cell surface to form an active signalling complex. Results: We report here the crystal structure of human oncostatin M (hOSM) along with mutagenesis data which map the receptor-binding epitopes of the molecule. The structure was determined to a resolution of 2.2 Angstrom and conforms to the haematopoietin cytokine up-up-down-down four-helix bundle topology. The site 2 epitope, responsible for gp130 binding, is centred around Gly120 which forms a 'dimple' on the surface of the molecule located on helices A and C. The site 3 motif, responsible for LIFR and OSMR binding, consists of a protruding Phe160/Lys163 pair located at the start of helix D. Conclusions: The data presented allow functional dissection of the receptor-binding interfaces to atomic resolution. Modelling suggests that the gp130 residue Phe169 packs into the site 2 dimple in an analogous fashion to structurally equivalent residues at the growth hormone-growth hormone receptor interface, implying that certain key features may underlie recognition across the whole cytokine/receptor superfamily, Conversely, detailed comparison of the available structures suggests that variations on a common theme dictate the specificity of receptor-ligand interactions within the gp130 family of cytokines.
引用
收藏
页码:863 / 874
页数:12
相关论文
共 52 条
[11]  
Ensoli F, 1999, J IMMUNOL, V162, P6268
[12]  
ESNOUF RM, 1997, J MOL GRAPHICS, V15, P133
[13]   TREATMENT OF NEGATIVE INTENSITY OBSERVATIONS [J].
FRENCH, S ;
WILSON, K .
ACTA CRYSTALLOGRAPHICA SECTION A, 1978, 34 (JUL) :517-525
[14]  
GEARING DP, 1992, NEW BIOL, V4, P61
[15]   The oncostatin M signalling pathway: reversing the neoplastic phenotype? [J].
Grant, SL ;
Begley, CG .
MOLECULAR MEDICINE TODAY, 1999, 5 (09) :406-412
[16]   Oncostatin M production and regulation by human polymorphonuclear neutrophils [J].
Grenier, A ;
Dehoux, M ;
Boutten, A ;
Arce-Vicioso, M ;
Durand, G ;
Gougerot-Pocidalo, MA ;
Chollet-Martin, S .
BLOOD, 1999, 93 (04) :1413-1421
[17]  
Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43
[18]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314
[19]   MOLECULAR-CLONING AND EXPRESSION OF AN IL-6 SIGNAL TRANSDUCER, GP130 [J].
HIBI, M ;
MURAKAMI, M ;
SAITO, M ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
CELL, 1990, 63 (06) :1149-1157
[20]   Solution structure of leukemia inhibitory factor [J].
Hinds, MG ;
Maurer, T ;
Zhang, JG ;
Nicola, NA ;
Norton, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13738-13745